Epiduo® Forte Gel

DRUG2 trials

Sponsors

Actavis Inc., Bausch Health Americas, Inc.

Conditions

AcneAcne Vulgaris

Phase 2

Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel

CompletedNCT04892706

Bausch Health Americas, Inc.Acne Vulgaris

Start: 2021-06-11End: 2022-09-28Updated: 2025-10-30

Phase 3

Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris

CompletedNCT02651220

Actavis Inc.Acne

Start: 2015-11-30End: 2016-10-31Updated: 2020-06-23

Related Papers

Early and Sustained Effects of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel

SKIN The Journal of Cutaneous Medicine2026-05-11

Efficacy and Safety of Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1%Compared With Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Participants With Moderate to Severe Acne

SKIN The Journal of Cutaneous Medicine2026-03-10

Efficacy and Safety of Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Asian Participants With Moderate to Severe Acne

SKIN The Journal of Cutaneous Medicine2025-11-10

Safety and Tolerability of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Truncal Acne.

2025-08-01

Safety and Tolerability of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Truncal Acne

SKIN The Journal of Cutaneous Medicine2025-07-23

Efficacy and Safety of Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Black Participants With Moderate to Severe Acne

SKIN The Journal of Cutaneous Medicine2025-07-23

Efficacy and Safety of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel: Post Hoc Analysis by Baseline Disease Severity.

2025-05-16

Efficacy and Safety of Fixed-dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Black Participants with Moderate to Severe Acne.

2025-04-01

Fixed‑Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Versus Adapalene 0.3%/Benzoyl Peroxide 2.5% Gels for Moderate‑to‑Severe Acne: Comparative Patient Journey

SKIN The Journal of Cutaneous Medicine2025-03-17

Efficacy and Safety of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel: Post Hoc Analysis by Baseline Disease Severity

SKIN The Journal of Cutaneous Medicine2024-11-18

Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne: Comparison of 4 Clinical Trials

SKIN The Journal of Cutaneous Medicine2024-07-23